Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 23, 2025 • 8:01 PM ET

Date/Time Source News Release
06/02/2025 08:10 AM EDT GlobeNewswire Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
05/20/2025 08:00 AM EDT GlobeNewswire Mersana Therapeutics to Present at Upcoming Investor Conferences
05/15/2025 09:20 AM EDT GlobeNewswire CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
05/15/2025 07:00 AM EDT GlobeNewswire Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
05/06/2025 07:00 AM EDT GlobeNewswire Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer
04/23/2025 10:12 AM EDT GlobeNewswire Mersana Therapeutics Announces Upcoming Emi-Le Oral and Poster Presentations at ASCO 2025 Annual Meeting
04/04/2025 04:05 PM EDT GlobeNewswire Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/01/2025 08:01 AM EDT GlobeNewswire Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
03/03/2025 07:01 AM EST GlobeNewswire Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results
02/25/2025 08:00 AM EST GlobeNewswire Mersana Therapeutics to Present at Upcoming Investor Conferences
Page

Additional News

As of June 23, 2025 • 8:01 PM ET

Date/Time Source News Release
05/15/2025 10:07 AM EDT SeekingAlpha Mersana extends cash runway into mid-2026 as restructuring narrows focus to breast cancer
05/15/2025 10:06 AM EDT SeekingAlpha Mersana Therapeutics, Inc. (MRSN) Q1 2025 Earnings Call Transcript
05/15/2025 08:15 AM EDT Zacks Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates
05/15/2025 07:07 AM EDT SeekingAlpha Mersana Therapeutics GAAP EPS of -$0.19 in-line, revenue of $2.75M misses by $3.3M
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:31 AM EDT US Earnings Reports Expected earnings - Mersana Therapeutics Inc.
05/14/2025 06:48 PM EDT KlickAnalytics MRSN - Historical Price Movements Surrounding Earnings
05/14/2025 06:43 PM EDT KlickAnalytics MRSN - Historical Earnings Price Analysis
05/14/2025 06:00 PM EDT SeekingAlpha Here are the major earnings before the open tomorrow
05/14/2025 11:53 AM EDT SeekingAlpha Mersana Therapeutics Q1 2025 Earnings Preview
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.